companydata.dkEurofins BioPharma Product Testing Denmark Holding A/S: Financial statements 2017
CVR: 37064408
Eurofins BioPharma Product Testing Denmark Holding A/S (CVR 37064408) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -109,688 and a net result of DKK 910,248 compared with DKK 583,998 the year before. Equity amounted to DKK 14,432,930. The solvency ratio was 24.1%.
- Gross Profit
- -109,688 kr.
- Profit/Loss
- 910,248 kr.
- Equity
- 14,432,930 kr.
- Total Assets
- 59,926,051 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -110 t. | 910 t. | 14.4 mio. | - |
| 2016 | - | -175 t. | 584 t. | 14 mio. | - |
Find more companies like Eurofins BioPharma Product Testing Denmark Holding A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2016. Gross profit came to DKK -174,784, and the net result was DKK 583,998.
About Eurofins BioPharma Product Testing Denmark Holding A/S
Eurofins BioPharma Product Testing Denmark Holding A/S is a Danish company of the type Aktieselskab based in Galten, founded in 2015. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Stefánia Pcolová. The company is owned by Eurofins Pharma Services LUX Holding SARL. In 2025, the company reported a gross profit of DKK -163,266 and a net result of DKK 8,356,614 compared with DKK -1,877,244 the year before. Equity amounted to DKK 24,787,263.